Wednesday - 10th May 2023
- 08:00
-
Registration & Refreshments
- 08:50
-
Chairperson’s opening remarks
Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
eMQT
- 09:00
-
Strategies for globalization in clinical trials
- Connecting the developed and the developing nations
- Dealing with differences owing to culture and ethnicity
- Role of CROs and third party stakeholders
Francis Crawley Executive Director
Good Clinical Practice Alliance - Europe (GCPA)
- 09:30
-
Stepping up the decentralization of clinical trials
Michael Zaiac Head of Medical Affairs Oncology Region Europe
Novartis
- 10:00
-
Innovative trial designs to save time and cost without compromising on the efficiency
- Strategies & Methods for flexible design trials
- The Adoption and Impact of Adaptive Trial Designs
- Preclinical environment and trial designs Opportunities and Limitations
For sponsorship opportunities please contact: sponsor@corvusglobalevents.com or call +44 (0) 207 096 0786
- 10:30
-
Morning Coffee/Tea & Networking
- 10:50
-
Medical Affairs and Clinical Operations collaborating on Clinical Trial Optimization
Viraj Rajadhyaksha Area Medical Director
AstraZeneca
Patient Recruitment & Site Selection
- 11:20
-
The National Institute for Health Research (NIHR) Patient Recruitment Centres: Optimising patient recruitment to ensure trial success
Richard Evans Head Of Business Development and Innovation
Leeds Teaching Hospitals NHS Trust
- 11:40
-
Innovative analytic technologies for predictive modelling, forecasting and optimal designing patient recruitment in clinical trials
- Advanced technologies to maximize patient recruitment predictability at different stages
- Optimal time-cost efficient recruitment design, sites/countries selection
- Data-driven re-projection and optimal adjustment of recruitment
- Centralized statistical monitoring and detecting unusual data patterns
- Predicting event counts in event-driven trials
Vladimir Anisimov Principal Data Scientist, Data Science, Center for Design & Analysis
Amgen
- 12:00
-
Monitoring and Quality Assurance in site selection and patient recruitment to optimize clinical trials
- Site pre-assessment and selection
- Ensure patient protection and to deliver high quality data
- Quality assurance can at times be difficult as regulatory requirements, standards and access to care differ globally – How are we going to handle this?
For sponsorship opportunities please contact: sponsor@corvusglobalevents.com or call +44 (0) 207 096 0786
- 12:20
-
Networking luncheons
- 13:10
-
The Impact of Diversity Plans on Increasing Overall Enrollment in Clinical Trials
Gayna B. Whitaker President and Founder
Genesis Medical Research Group
- 13:40
-
Enrolment and retention in clinical studies before and during Covid-19 pandemic: clinical challenges and new opportunities. A case report from a phase 3 clinical program in fibromyalgia
- What will persuade and impact the patient?
- Is there anything pharma can provide for a trial member that will increase the value of participation?
- The aim of patient-driven clinical trials is to diminish the burden of participation by making the participant journey as convenient and pleasant as possible
- Utilize fitting procedures and techniques to limit dropouts without, in any capacity, constraining a patient to remain in the study
Domenico Merante Clinical Research Lead TA Orphan-Nephrology
CSL Vifor
- 14:10
-
Panel discussion: Critical Success Factors while Planning for Site Selection and Patient Recruitment
- Discover sites with a demonstrated track record of good execution in trials
- Study and site staff with solid certifications to expand the likelihood of powerful enrolment and an effective trial.
- Factors such as disease prevalence rates, treatment practices, regulatory requirements and statistical considerations must be considered.
- Access to subject population with the required eligibility criteria
- Network within industries
Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
eMQT
Diane Driver Head Program Delivery
UCB
Joanne Stevens Global Head of R&D Operations
GE Healthcare
- 14:40
-
How Can African Sites be routinely included? Addressing diversity at its core
- Addressing and overcoming the fears
- Understanding and removing the challenges
- Providing robust tools to gather evidence
Tina Barton Chief Operating Officer
eMQT
Shalom Lloyd Co-Founder & Chief Strategy Officer
eMQT
- 15:10
-
Afternoon Tea/Coffee
Patient Centricity & Patient Engagement
- 15:30
-
Patient Engagement in Clinical Development - A look at what the UK are doing to bring patients to the forefront of study design
Alex Hammond Business Development Manager
NIHR Clinical Research Network
- 16:00
-
EU-PEARL: An EU patient-centric clinical trial platform
Nadir Ammour Global Lead, Clinical Innovation & External Partnership
Sanofi
- 16:30
-
Panel Discussion: Putting the patient first - Embedding a patient-centric approach to clinical trial design
Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
eMQT
- 17:00
-
Interactive Breakout Discussions
All the participants will have a great opportunity to discuss and explore a selection of most interesting topics discussed during the conference in small groups with their industry colleagues in an informal setting.
Round Table 1: Innovation in Clinical Trials - Digital Approaches
Round Table 2: Patient Centricity
Round Table 3: Globalization and Country Specifics
Round Table 4: Recruitment Challenges - Patients and Sites
Round Table 5: Changing Clinical Trials - What needs to be addressed
Round Table 6: Patient Retention
- 17:50
-
Chairperson’s closing remarks
Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
eMQT
- 18:00
-
Networking Drinks Session
Stay Informed
Subscribe today to receive news on latest updates,
offers and upcoming conferences via email
follow us
Follow us online to stay up to date about our conferences
For general conference and registration enquires please contact the below email id or fill out the form
info@corvusglobalevents.com
+44 (0) 207 096
0786
